在宅ヘルスケア機器の世界市場 - 2025年～2033年

在宅ヘルスケア機器の世界市場は2024年に462億5,000万米ドルに達し、2033年には822億7,000万米ドルに達すると予測され、予測期間予測期間2025年～2033年のCAGRは6.8%で成長します。

在宅ヘルスケア機器は、個人が健康状態を管理するために家庭で使用できる一連の医療機器および技術です。医療機関に定期的に通うことなく、これらの機器を使ってさまざまな医療上の問題をモニタリングしたり治療したりすることができ、ヘルスケアへのより快適で便利なアプローチをサポートします。在宅治療への需要の高まりは、必要な治療を受けながら自立した生活を維持したいというヘルスケア分野の大きな動向を反映しています。

在宅治療に対する患者の需要の増加が、予測期間中の市場を牽引する要因となっています。在宅ヘルスケアへの移行には、高齢化、慢性疾患の有病率の増加、在宅ケアの実現可能性と有効性を向上させる医療技術の開発など、いくつかの要因が寄与しています。

市場力学：

促進要因と抑制要因

在宅治療に対する患者の需要の増加

在宅治療に対する患者の需要の増加は、世界の在宅ヘルスケア機器市場の成長における重要な要因になると予想されます。この動向は、人口の高齢化、慢性疾患の有病率の上昇、技術の進歩、自宅での効果的なケアを促進する機器への人工知能の導入など、相互に関連するいくつかの要因が主な要因となっています。高齢者人口の拡大は、高齢者特有のヘルスケアニーズにより、世界の在宅医療機器市場に大きな影響を与えています。高齢になると、継続的な治療と監視を必要とする慢性疾患を発症する可能性が高くなります。

老人人口の増加は、在宅治療の需要増加の主な理由の一つです。例えばWHOによると、2050年には高齢者の80％が低・中所得国に住むようになるといいます。高齢化のスピードは、過去に比べてはるかに速くなっています。2020年には、60歳以上の人口が5歳未満の子どもを上回る。2015年から2050年にかけて、世界の人口に占める60歳以上の割合は12％から22％へとほぼ倍増します。2030年には、世界の6人に1人が60歳以上となります。

技術の進歩、最近の発売、さまざまな機器のFDA承認が市場を牽引しています。例えば、2024年11月、メドトロニックは新しいInPenスマートフォンソフトウェアの米国食品医薬品局（FDA）の承認を取得し、新しいSmart MDIシステムのリリースを発表しました。スマートMDIは、1日複数回注射（MDI）療法に関するリアルタイムの情報をユーザーに提供するために開発されました。

さらに、2024年9月、アボット・ラボラトリーズは、市販の持続グルコースモニターLingoが米国で発売されたことを発表しました。アボットの主な目標の1つは、Lingoのユーザーが血流中の糖分が急激に増減する際に発生するグルコーススパイクについて学ぶのを助けることです。

高価な機器

医療機器の高コストなどの要因が、世界の在宅ヘルスケア機器市場を阻害すると予想されています。医療機器のコストが高いことは、潜在的な消費者にとって大きな懸念材料です。インスリンポンプ、ネブライザー、高度モニタリングシステムなど、多くの在宅ヘルスケア製品には高価格がつきものであり、患者の購入を妨げる可能性があります。このような医療機器に対する保険適用が低い、あるいは存在しない地域では特にそうであり、患者は全費用を自分で負担しなければならないです。例えば、インスリン送達システムの平均価格は3,000ドルから6,000ドルです。このことは、このような重要な装置を使用する際に人々が被る費用負担の大きさを浮き彫りにしています。

目次

第1章 調査手法と調査範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

• 影響要因
  • 促進要因
  • 在宅治療に対する患者の需要増加
  • 抑制要因
  • 医療機器の高コスト
  • 機会
  • 影響分析

第5章 産業分析

• ポーターのファイブフォース分析
• サプライチェーン分析
• 価格分析
• 規制分析
• 償還分析
• 特許分析
• SWOT分析
• DMIの見解

第6章 治療機器別

• インスリン送達システム
• 家庭用透析装置
• 呼吸器
• その他

第7章 監視デバイス別

• 血糖値測定器
• 血圧モニター
• 温度監視装置
• パルスオキシメーター
• その他

第8章 モビリティケアデバイス

• 車椅子
• ウォーカー
• モビリティスクーター
• その他

第9章 流通チャネル別

• 病院薬局
• 小売薬局
• オンライン薬局

第10章 地域別

• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • イタリア
  • スペイン
  • その他欧州地域
• 南米
  • ブラジル
  • アルゼンチン
  • その他南米
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• 中東・アフリカ

第11章 競合情勢

• 競合シナリオ
• 市況・シェア分析
• M&A分析

第12章 企業プロファイル

• Invacare Corporation
  • 会社概要
  • 製品ポートフォリオと概要
  • 財務概要
  • 主な発展
• Karman Healthcare Inc.
• Ottobock
• Pride Mobility Products Corp.
• Medtronic
• Sunrise Medical
• Meyra GmbH
• Koninklijke Philips N.V.
• Nihon Kohden Corporation
• Danaher Corporation

第13章 付録

The global home healthcare devices market reached US$ 46.25 billion in 2024 and is expected to reach US$ 82.27 billion by 2033, growing at a CAGR of 6.8% during the forecast period 2025-2033.

Home healthcare devices are a set of medical devices and technologies that individuals can use at home to manage their health conditions. Individuals can use these devices to monitor and treat a variety of medical concerns without having to make regular visits to healthcare institutions, supporting a more comfortable and convenient approach to healthcare. The growing demand for home-based care reflects a larger trend in the healthcare sector, in which people want to keep their independence while obtaining necessary medical treatment.

The increased patient demand for home-based treatments is the driving factor that drives the market over the forecast period. Several factors contribute to this move toward home healthcare, including an aging population, an increase in the prevalence of chronic diseases, and developments in medical technology that improve the feasibility and effectiveness of home-based care.

Market Dynamics: Drivers & Restraints

Increased patient demand for home-based treatments

The increased patient demand for home-based treatments is expected to be a significant factor in the growth of the global home healthcare devices market. This trend is primarily fueled by several interconnected factors, including the aging population, the rising prevalence of chronic diseases, and advancements in technology, introduction of artificial intelligence in the devices that facilitate effective care at home. The expanding geriatric population has a substantial impact on the global home medical equipment market, owing to older persons' specific healthcare needs. As people age, they are more likely to develop chronic diseases that require continuing medical treatment and monitoring.

The increase in the geriatric population is one of the major reasons for the increasing demand of the home-based treatment. For instance, according to WHO, in 2050, 80% of older people will be living in low- and middle-income countries. The pace of population aging is much faster than in the past. In 2020, the number of people aged 60 years and older outnumbered children younger than 5 years. Between 2015 and 2050, the proportion of the world's population over 60 years will nearly double from 12% to 22%. By 2030, 1 in 6 people in the world will be aged 60 years or over.

The technological advancements, recent launches, and FDA approvals of various devices drives the market. For instance, in November 2024, Medtronic received U.S. Food and Drug Administration (FDA) approval for its new InPen smartphone software and announced the release of its new Smart MDI system. Smart MDI was created to give users real-time information about multiple daily injection (MDI) therapy.

Moreover, in September 2024, Abbott Laboratories announced that its over-the-counter continuous glucose monitor Lingo is available in the U.S. One of Abbott's primary goals is to help Lingo users learn about glucose spikes, which occur when the amount of sugar present in the bloodstream rapidly increases and then decreases.

High costs of devices

Factors such as high costs of devices are expected to hamper the global home healthcare devices market. The high cost of medical devices is a major concern for potential consumers. Many home healthcare products, such as insulin pumps, nebulizers, and advanced monitoring systems, come with high prices that may hinder patients from purchasing them. This is especially true in areas where insurance coverage for such devices is low or non-existent, requiring patients to face the entire expense themselves. For instance, the average price of the insulin delivery system ranges from $3,000 to $ 6,000. This highlights the substantial cost burden that people suffer when using these vital devices.

Segment Analysis

The global home healthcare devices market is segmented based on therapeutic devices, monitoring devices, mobility care devices, distribution channels, and region.

Monitoring devices segment is expected to dominate the global home healthcare devices market share

The monitoring devices segment is anticipated to dominate the global home healthcare devices market. The monitoring devices segment is expected to lead the worldwide home healthcare devices market due to several interconnected variables that represent the changing face of healthcare. As chronic diseases become more common, there is an increased demand for ongoing health monitoring, particularly among older persons and those with long-term health concerns. This shift toward proactive health management stresses the relevance of patient monitoring devices, which enable people to follow vital signs and other health metrics from home, allowing for more prompt interventions and lowering the need for hospital visits.

For instance, in August 2024, Dexcom announced the launch of an over-the-counter continuous glucose monitor. Dexcom's Stelo monitors blood glucose levels constantly via a wearable sensor and an application on the user's smartphone or other smart device. Moreover, in June 2024, Prevounce Health, a leading provider of remote care management software, devices, and services, announced the launch of its first remote blood glucose monitoring device, Pylo GL1-LTE. The blood glucose meter has been scientifically tested and linked to numerous cellular networks to guarantee more dependable data transmission across the United States. The GL1-LTE is compatible with the Prevounce remote care management platform and may be integrated with other health software using the Pylo cloud API. Prevounce's Pylo cellular-connected gadgets include blood pressure monitors and weight scales.

Geographical Analysis

North America is expected to hold a significant position in the global home healthcare devices market share

North America is expected to hold a significant portion of the global home healthcare devices market. North America will likely dominate the global home healthcare devices market, owing to a combination of demographic, economic, and technical factors. The region benefits from a well-established healthcare infrastructure that encourages the use of home healthcare solutions. As the geriatric population and frequency of chronic diseases increases, so does the demand for home medical equipment that enables patients to properly manage their health conditions from the comfort of their own homes. This trend to home-based treatment not only improves patient comfort but also decreases the pressure on healthcare facilities, making it a popular choice among many individuals and families.

For instance, according to urban.org, the number of Americans aged 65 and older will more than double over the next 40 years, reaching 80 million in 2040. The number of adults ages 85 and older, the group most often needing help with basic personal care, will nearly quadruple between 2000 and 2040. For an instance, according to America Health Ranking.org, 17.3% of the entire US population is geriatric population.

There are major players present in this region which makes this region the most dominating. For instance, in November 2024, Medtronic received U.S. Food and Drug Administration (FDA) approval for its new InPen smartphone software and announced the release of its new Smart MDI system. Smart MDI was created to give users real-time information about multiple daily injection (MDI) therapy.

Asia Pacific is growing at the fastest pace in the global home healthcare devices market

The Asia Pacific region is emerging as the fastest-growing market for home healthcare devices. One of the major contributions to this growth is the rising prevalence of chronic diseases in the population and the increasing geriatric population. Diabetes, cardiovascular diseases, and respiratory ailments are growing increasingly prevalent as people's lifestyles change and urbanization accelerates. The rise in chronic diseases demands continual monitoring and management, making home medical devices crucial for individuals who prefer to manage their health at home rather than visit healthcare facilities.

The increasing geriatric population is one of the driving factors in this region making it the fastest growing region. For instance, according to the UNFPA India, the current elderly population of 153 million (aged 60 and above) is expected to reach a staggering 347 million by 2050.

Competitive Landscape

The major global players in the global home healthcare devices market include Invacare Corporation, Karman Healthcare Inc., Ottobock, Pride Mobility Products Corp., Medtronic, Sunrise Medical, Meyra GmbH, Koninklijke Philips N.V., Nihon Kohden Corporation, Danaher Corporation among others.

Emerging Players

Livongo, Tyto Care, and iRhythm Tech among others

Key Developments

• In August 2024, Hong Kong-based health tech start-up Libpet introduced its innovative smart robot wheelchairs, designed not only for the physically challenged but for everyone. By reducing physical effort, the inclusive device enhances mobility and productivity, making life significantly easier.
• In November 2023, DuPont announced a collaboration between DuPont Liveo Healthcare Solutions and STMicroelectronics, a global leader in semiconductor technology. Together, they are working on the development of a new smart wearable device concept aimed at remote biosignal monitoring.

Why Purchase the Report?

• Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
• Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
• Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
• Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
• Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
• Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
• Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
• Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
• Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
• Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
• Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
• Post-market Surveillance: Uses post-market data to enhance product safety and access.
• Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global home healthcare devices market report delivers a detailed analysis with 60+ key tables, more than 50 visually impactful figures, and 176 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

• Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
• Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
• Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
• Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
• Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
• Supply Chain: Distribution and Supply Chain Managers.
• Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
• Academic & Research: Academic Institutions.

Table of Contents

1. Methodology and Scope

• 1.1. Research Methodology
• 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

• 3.1. Snippet by Therapeutic Devices
• 3.2. Snippet by Monitoring Devices
• 3.3. Snippet by Mobility Care Devices
• 3.4. Snippet by Distribution Channel
• 3.5. Snippet by Region

4. Dynamics

• 4.1. Impacting Factors
  • 4.1.1. Drivers
  • 4.1.2. Increased Patient Demand For Home-based Treatments
  • 4.1.3. Restraints
  • 4.1.4. High Cost of Medical Equipment
  • 4.1.5. Opportunity
  • 4.1.6. Impact Analysis

5. Industry Analysis

• 5.1. Porter's Five Force Analysis
• 5.2. Supply Chain Analysis
• 5.3. Pricing Analysis
• 5.4. Regulatory Analysis
• 5.5. Reimbursement Analysis
• 5.6. Patent Analysis
• 5.7. SWOT Analysis
• 5.8. DMI Opinion

6. By Therapeutic Devices

• 6.1. Introduction
  • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Therapeutic Devices
  • 6.1.2. Market Attractiveness Index, By Therapeutic Devices
• 6.2. Insulin Delivery Systems*
  • 6.2.1. Introduction
  • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 6.3. Home Dialysis Machines
• 6.4. Respiratory Devices
• 6.5. Others

7. By Monitoring Devices

• 7.1. Introduction
  • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Monitoring Devices
  • 7.1.2. Market Attractiveness Index, By Monitoring Devices
• 7.2. Blood Glucose Meters*
  • 7.2.1. Introduction
  • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 7.3. Blood Pressure Monitors
• 7.4. Temperature Monitoring Devices
• 7.5. Pulse Oximeters
• 7.6. Others

8. By Mobility Care Devices

• 8.1. Introduction
  • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mobility Care Devices
  • 8.1.2. Market Attractiveness Index, By Mobility Care Devices
• 8.2. Wheelchairs*
  • 8.2.1. Introduction
  • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 8.3. Walkers
• 8.4. Mobility Scooters
• 8.5. Others

9. By Distribution Channel

• 9.1. Introduction
  • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
  • 9.1.2. Market Attractiveness Index, By Distribution Channel
• 9.2. Hospital Pharmacies*
  • 9.2.1. Introduction
  • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 9.3. Retail Pharmacies
• 9.4. Online Pharmacies

10. By Region

• 10.1. Introduction
  • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
  • 10.1.2. Market Attractiveness Index, By Region
• 10.2. North America
  • 10.2.1. Introduction
  • 10.2.2. Key Region-Specific Dynamics
  • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), Therapeutic Devices
  • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Monitoring Devices
  • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mobility Care Devices
  • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
  • 10.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  • 10.2.8. The U.S.
  • 10.2.9. Canada
  • 10.2.10. Mexico
• 10.3. Europe
  • 10.3.1. Introduction
  • 10.3.2. Key Region-Specific Dynamics
  • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), Therapeutic Devices
  • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Monitoring Devices
  • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mobility Care Devices
  • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
  • 10.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  • 10.3.8. Germany
  • 10.3.9. UK
  • 10.3.10. France
  • 10.3.11. Italy
  • 10.3.12. Spain
  • 10.3.13. Rest of Europe
• 10.4. South America
  • 10.4.1. Introduction
  • 10.4.2. Key Region-Specific Dynamics
  • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), Therapeutic Devices
  • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Monitoring Devices
  • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mobility Care Devices
  • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
  • 10.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  • 10.4.8. Brazil
  • 10.4.9. Argentina
  • 10.4.10. Rest of South America
• 10.5. Asia-Pacific
  • 10.5.1. Introduction
  • 10.5.2. Key Region-Specific Dynamics
  • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), Therapeutic Devices
  • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Monitoring Devices
  • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mobility Care Devices
  • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
  • 10.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  • 10.5.8. China
  • 10.5.9. India
  • 10.5.10. Japan
  • 10.5.11. South Korea
  • 10.5.12. Rest of Asia-Pacific
• 10.6. Middle East and Africa
  • 10.6.1. Introduction
  • 10.6.2. Key Region-Specific Dynamics
  • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), Therapeutic Devices
  • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Monitoring Devices
  • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mobility Care Devices
  • 10.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel

11. Competitive Landscape

• 11.1. Competitive Scenario
• 11.2. Market Positioning/Share Analysis
• 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

• 12.1. Invacare Corporation*
  • 12.1.1. Company Overview
  • 12.1.2. Product Portfolio and Description
  • 12.1.3. Financial Overview
  • 12.1.4. Key Developments
• 12.2. Karman Healthcare Inc.
• 12.3. Ottobock
• 12.4. Pride Mobility Products Corp.
• 12.5. Medtronic
• 12.6. Sunrise Medical
• 12.7. Meyra GmbH
• 12.8. Koninklijke Philips N.V.
• 12.9. Nihon Kohden Corporation
• 12.10. Danaher Corporation

LIST NOT EXHAUSTIVE

13. Appendix

• 13.1. About Us and Services
• 13.2. Contact Us